Thongprasert, S., Duffield, E., Saijo, N., Wu, Y. L., Yang, J. C. H., Chu, D. T., . . . Fukuoka, M. (2018). Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
Chicago Style CitationThongprasert, Sumitra, et al. Health-related Quality-of-life in a Randomized Phase III First-line Study of Gefitinib Versus Carboplatin/paclitaxel in Clinically Selected Patients From Asia With Advanced NSCLC (IPASS). 2018.
MLA引文Thongprasert, Sumitra, et al. Health-related Quality-of-life in a Randomized Phase III First-line Study of Gefitinib Versus Carboplatin/paclitaxel in Clinically Selected Patients From Asia With Advanced NSCLC (IPASS). 2018.